Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): A phase 2b randomised, controlled, partly blinded trial

Samir K. Gupta, Grace A. McComsey, John Lombaard, Juan Echevarría, Catherine Orrell, Anchalee Avihingsanon, Olayemi Osiyemi, Mario Santoscoy, Neelanjana Ray, David A. Stock, Samit R. Joshi, George J. Hanna, Max Lataillade

Research output: Contribution to journalArticle

6 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): A phase 2b randomised, controlled, partly blinded trial'. Together they form a unique fingerprint.

Medicine & Life Sciences